Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Reducing systemic regulatory t cell levels or activity for treatment of disease and injury of the CNS

Reducing systemic regulatory t cell levels or activity for treatment of disease and injury of the CNS

US Patent 11492405 · Granted Nov 8, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Reducing systemic regulatory T cell levels or activity for treatment of amyotrop2024
Reducing systemic regulatory T cell levels or activity for treatment of amyotrop2024
Reducing systemic regulatory T cell levels or activity for treatment of amyotrop2024
Reducing systemic regulatory T cell levels or activity for treatment of amyotrop2024
Reducing systemic regulatory T cell levels or activity for treatment of amyotrop2024
Reducing systemic regulatory T cell levels or activity for treatment of amyotrop2024
Modified anti-PD-L1 antibody and methods and uses for treating a neurodegenerati2023
Modified anti-PD-L1 antibody and methods and uses for treating a neurodegenerati2023
Reducing systemic regulatory T cell levels or activity for treatment of a retina2023
Reducing systemic regulatory T cell levels or activity for treatment of a retina2023
Reducing systemic regulatory T cell levels or activity for treatment of a retina2023
Modified anti-PD-L1 antibody and methods and uses for treating a neurodegenerati2021